Skip to main content

Diabetes

  • Recreating islet cells can boost insulin production, study finds

    NEW YORK — In patients with Type 1 diabetes, the islet cells of the pancreas are destroyed, thus eliminating the organ’s ability to produce insulin.

    But researchers at Georgetown University have found a way to recreate them using cells from the testicles, according to published reports.

    WebMD reported that the researchers took the testicular tissue, extracted the stem cells and used them to create new islet cells. Injecting them into the pancreases of mice with diabetes. The researchers found that the cells began to secrete insulin.

  • Special Diabetes Program reauthorized by Congress

    ALEXANDRIA, Va. — A decision by Congress to reauthorize the Special Diabetes Program has drawn praise from the American Diabetes Association.

    The program was part of the Medicare and Medicaid Extenders Act of 2010 and will ensure continuance through 2013 of the Special Diabetes Program for American Indians while providing $150 million per year in funding.

  • Walgreens unveils benefits of Dimensions project

    DEERFIELD, Ill. — Pharmacists who intervene with diabetes patients are having a clear and positive impact on clinical outcomes, a new study from Walgreens has found.

  • Combining Lilly and Amylin drug with insulin intake found to promote weight loss

    CHAPEL HILL, N.C. — Combining a diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals controls blood sugar and promotes weight loss more than insulin alone, according to a new study.

  • Registered dietitians most likely to practice what they preach

    NEW YORK — Registered dietitians are the most likely to practice what they preach in eating a balanced diet, taking vitamins or other dietary supplements, exercising regularly and engaging in other wellness behaviors as compared with seven other healthcare professional populations, according to the “Life…supplemented” "Healthcare Professionals Impact Studies" released earlier this week by the Council for Responsible Nutrition.

  • Women with diabetes may suffer from low sex drive, study finds

    CARY, N.C. — Almost half of women in the United States who suffer from diabetes reported that it has a negative impact on their sex lives, according to a new study released Tuesday by MicroMass Communications.

    The research, which highlighted the need for improved education and support to help women build confidence in their ability to overcome the challenges of the disease, was conducted with a representative sample of more than 800 women with diabetes.

  • FDA panel backs Contrave

    SAN DIEGO — A Food and Drug Administration advisory committee has recommended approval for an investigational diet pill.

    Orexigen Therapeutics and Takeda Pharmaceutical announced Tuesday that the FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 13-7 that clinical trial data demonstrated that the benefits of the drug Contrave (naltrexone and bupropion) outweighed its risk and supported approval. The committee also voted 11-8 to recommend a study to examine Contrave’s effect on risk for cardiac disease.

  • Q&A: Synergetic strategy — Scott Verner, Nipro Diagnostics

    Drug Store News recently sat down with Scott Verner, president of Nipro Diagnostics, to discuss some of the synergies created by the acquisition of Home Diagnostics by Japan’s Nipro in March. 


    Drug Store News: How is the new company better positioned in the U.S. market? What are the synergies?


X
This ad will auto-close in 10 seconds